Micro-dosing Psychedelics with Potentiating Admixtures to Alleviate Depression and Inflammation in the Gut-Brain-Heart Energy Fields

Written By SykoActive

SykoActive had another Stellar interview with a Connoisseur of Consciousness Expanding Chemicals, Darryl Hudson.

Darryl has a PHd in molecular biology and neuroscience and is an expert studying psychedelic genetics and new formulations using potentiating admixtures. We talk about micro-dosing psychedelics to alleviate depression, inflammation, and the importance of a healthy gut/heart/brain flowing energy chakra connection. He co-founded InPlanta Biotechnology Inc. and Pathways Rx, where he led the development and commercialization of proprietary plant genetics. Also the Co-founder and Chief Innovation Officer at GoodCap Pharmacueticals.

D. Darryl Hudson (born Lethbridge, Alberta, 1982) is a Canadian scientist and musician based in Alberta, who specializes in the breeding, cultivation, extraction and formulation of Cannabis. Hudson was awarded the Alexander Graham Bell Canada graduate scholarship and the first Mitacs Industrial post-doctoral fellowship award and received his PhD in molecular biology and genetics from Guelph University in 2010 specializing in genetic engineering of crop plants. Dr. Hudson also performs studies and clinical research on psilocybin (magic mushrooms).

Hudson is an expert in cannabis and fungi and has contributed to groundbreaking studies of the genetics of Cannabis. Actively breeding hemp crops in Canada and abroad, Hudson has pioneered plant and natural extraction protocols focusing on efficient and safe methods for removal and separation of medical molecules.

Hudson has been active in studying effects of Cannabis and fungi in treating post-traumatic stress disorder (PTSD) specifically working with military veterans to develop both medications and protocols. Hudson spoke to the US Senate, prior to the groundbreaking legislation that allowed US veterans to receive recommendations for medical marijuana. He continues to speak at many international conferences.

Hudson is also co-author of numerous peer-reviewed scientific publications and research articles, on plant biology, plant genetics, DNA repair, epigenetics, cancer and Cannabis.




SykoActive

Graham Krutch, also known as 'Gram Kracker,' is the founder and CEO of SykoActive Non-Profit Association, boasting over two decades of experience in the industry of medicinal plants and psychedelic substances. His expertise extends from cultivation to patient consultation, primarily focusing on cannabis and psilocybin, alongside notable advancements in the hemp and CBD sector.

Under Graham's guidance, SykoActive investigates and advocates for the therapeutic uses of psychedelic plant medicines. He is committed to informing the public about secure alternative treatments and tackling the worldwide mental health dilemma.

Beyond his involvement in the psychedelic realm, Graham possesses a varied skill set in event marketing and product management. His efforts have been instrumental in the prosperity of leading convenience stores, and he shines in team leadership, strategic planning, and project management. As a fervent proponent of Applied AI Science and proficient in AI research and technological tools, he adeptly merges a customer-centric approach with an acute awareness of time constraints.

https://www.sykoactive.com
Previous

Enlightened Psychedelic Guide, Higher Consciousness Coaching, & Micro-dosing with Sarah Hope
Next

Entheogenic Churches Religious Right To Use Psychedelics